tirzepatide studies 2025 Market Size to Touch USD 116.01 Billion by 2035 A network meta-analysis backed weight-loss

Potential Side Effects 2-4 Decreased libido Decreased energy levels Headache Nausea Estrogenic side effects such as gynecomastia, bloating or mood swings (less incidence compared to clomiphene) Handling Requirements Keep away from children and pets Enclomiphene is a selective estrogen receptor modulator (SERM)

Foundayo (Orforglipron) Foundayo is the latest addition to the FDA-approved GLP-1 weight loss medications

(10) Goldstein RH, et al

Haverty T, Wyatt DJ, Porter KM, Leubitz A, Banks K, Goodyer P, Hu MY (2021) Phase 1 renal impairment trial results supports targeted individualized dosing of ELX-02 in patients with nephropathic cystinosis